TipRanks
Go Ultimate55% OFF

Shree Ram Proteins Ltd. (SRPL) AI Stock Analysis

IN:SRPL

Shree Ram Proteins Ltd.

(NSE:SRPL)

Select Model
Rating:38Underperform
Price Target:INR 0.32â–¼(-5.88% Downside)
Action:reiterated
Date:09/24/26

The overall stock score of 38 reflects extreme financial and operational distress. The most significant factor is the complete cessation of revenue generation, which has caused massive equity erosion and unsustainable debt levels. Firmly bearish technical trends and distressed valuation metrics further compound the severe downside risk, making the stock highly speculative.

Positive Factors
Historical ProfitabilityThe company demonstrated an ability to generate profit in three consecutive years before the recent downturn. This history shows that the operating model has previously supported positive earnings, providing a foundation for recovery if revenue and margins stabilize.
Negative Factors
Severe Earnings DeteriorationThe shift from recurring profits to three consecutive years of large losses indicates a substantial deterioration in the economics of the business. Persistent losses can weaken reinvestment capacity, reduce financial resilience, and make a durable earnings recovery dependent on restoring operations and margins.

Shree Ram Proteins Ltd. (SRPL) vs. iShares MSCI India ETF (INDA)

-60%-50%-40%-30%-20%-10%0%10%IN:SRPL-50.72%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 145.66M
Dividend Yield
―
Average Volume (3M)
253.74K
Price to Earnings (P/E)
-0.5
Beta (1Y)
0.45
Revenue Growth
―
EPS Growth
43.06%
Country
India
Employees
24
Sector
General
Sector Strength
55
Industry
Agricultural Farm Products

Shree Ram Proteins Ltd. Business Overview & Revenue Model

Company Description

Shree Ram Proteins Limited, an Indian company, specializes in the processing of cotton seeds. Its product portfolio is extensive, featuring various cotton seed derivatives like linter, meal, hull, and both wash and refined oils. Beyond cotton, the co...

How the Company Makes Money

SRPL generates revenue primarily through the sale of agricultural commodity products and related processed outputs (i.e., revenue recognized when commodities/finished goods are delivered/sold to customers). Key revenue streams typically include (a) t...

Shree Ram Proteins Ltd. Financial Statement Overview

Summary

The company is experiencing severe financial distress, highlighted by zero revenue over the past two years, massive net losses, and dangerously high leverage with a debt-to-equity ratio of 2.42. The deeply negative return on equity and structurally unsustainable cash flows pose critical existential threats.

Income Statement

5Very Negative

Balance Sheet

15Very Negative

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue146.00K00147.66M1.63B2.88B
Gross Profit-60.85M-61.39M-195.24M-45.57M145.69M174.93M
EBITDA-79.56M-91.70M-169.38M-78.65M105.07M136.20M
Net Income-146.53M-101.08M-210.75M-95.85M38.45M61.41M
Balance Sheet
Total Assets0694.70M787.27M982.56M1.06B1.16B
Cash, Cash Equivalents and Short-Term Investments135.00K135.00K136.00K970.00K425.00K313.31M
Total Debt0371.45M381.37M369.40M369.48M425.14M
Total Liabilities-153.42M541.28M532.49M517.65M500.07M638.17M
Stockholders Equity153.42M153.42M254.79M464.91M560.73M522.31M
Cash Flow
Free Cash Flow09.73M-12.81M5.83M-214.48M360.12M
Operating Cash Flow09.73M-12.81M5.86M-202.00M362.66M
Investing Cash Flow0283.00K09.04M-12.39M-2.44M
Financing Cash Flow0-10.02M11.97M-14.35M-98.50M-56.87M

Shree Ram Proteins Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price0.34

Price Trends

50DMA0.34Negative
100DMA0.35Negative
200DMA0.42Negative

Market Momentum

MACD-0.00Negative
RSI42.95Neutral
STOCH100.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SRPL, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.34, below the 50-day MA of 0.34, and below the 200-day MA of 0.42, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 42.95 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SRPL.

Shree Ram Proteins Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:SRPL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:GODREJAGROIN:GODREJAGRO72OutperformINR 106.57B23.82―1.99%8.58%-1.86%
IN:DBOLIN:DBOL64NeutralINR 7.79B9.21―1.27%10.24%―
IN:MGELIN:MGEL59NeutralINR 5.74B14.41―0.06%44.23%8.18%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:VENKEYSIN:VENKEYS53NeutralINR 21.12B12.22―0.67%18.28%202.79%
IN:SANWARIAIN:SANWARIA43NeutralINR 360.69M-3.70――296.49%19.23%
IN:SRPLIN:SRPL38UnderperformINR 145.66M-0.50―――43.06%

* General Sector Average

Performance Comparison

-50%0%50%IN:SRPLIN:DBOLIN:GODREJAGROIN:MGELIN:SANWARIAIN:VENKEYSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:SRPL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:SRPLShree Ram Proteins Ltd.0.34-0.38-52.78%
IN:DBOLDhampur Bio Organics Ltd117.3538.4548.73%
IN:GODREJAGROGodrej Agrovet Limited553.85-94.65-14.59%
IN:MGELMangalam Global Enterprise Ltd.17.413.3123.47%
IN:SANWARIASanwaria Consumer Ltd0.490.000.00%
IN:VENKEYSVenky's (India) Limited1499.25-24.66-1.62%

Shree Ram Proteins Ltd. Corporate Events

Shree Ram Proteins Shareholders Approve Related-Party Sale of Undertaking via E-Voting

Aug 18, 2026

Shree Ram Proteins Ltd. conducted an Extraordinary General Meeting (EOGM) on March 5, 2026, via video conferencing, where shareholders participated through remote and live e-voting facilitated by NSDL in compliance with Ministry of Corporate Affairs...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026